QT Imaging Holdings, Inc. QTI
Biotechnology: Electromedical & Electrotherapeutic Apparatus · data as of November 13, 2026
QT Imaging Holdings, Inc. (QTI) is a healthcare company listed in the US with a market value of about $28M. In the twelve months to September 30, 2026 it had revenue of $30M and net income of -$16M, a net margin of -54.6%.
Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (3/5); the weakest is track record (0/5).
Key numbers: a 5-year average ROIC of -430%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 7% above the current price.
About QT Imaging
QT Imaging is listed in the US and classified in biotechnology: electromedical & electrotherapeutic apparatus. It was profitable in 0 of the last 5 years in our data. Its share count rose by 381% over three years (dilution for shareholders). It spends 21% of revenue on research and development.
Score: 1.0 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
- Revenue growth above 10% last year
- Profit margin improving
- Strong R&D investment or growth above 20%
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 5 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $30M | $19M | $5M | $40355 | $0 | — |
| Net income | -$16M | -$21M | -$9M | -$6M | -$3M | -$1M |
| Free cash flow | -$14M | -$9M | -$10M | -$3M | — | — |
| EPS (diluted) | $-0.91 | $-2.01 | $-2.13 | $-1.92 | $-1.80 | $-0.42 |
| Net margin | -54.6% | -111.4% | -184.2% | -15113.2% | — | — |
| ROIC | — | -25.8% | -833.5% | — | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 4 analysts is $8.75, 365% above the current price; targets range from $6.00 to $12.00; the consensus rating is “Strong buy”; expected EPS is $-1.01 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is QT Imaging stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 7% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does QT Imaging pay a dividend?
Not currently.
Is QT Imaging a good stock to buy?
We do not give buy or sell advice. QT Imaging scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.